European Pharmaceutical Review Issue 1 2019
In this issue we look at the challenges of shipping temperature-controlled products, the potential use of blockchain for pharma, and using MALDI-TOF for identification of peptides in suspected illegal medicinal products. The edition also includes articles on aseptic containment, legal advice on licensing negotiations and an In-Depth Focus article from near-infrared spectroscopy pioneer Emil Ciurczak.
Included in this issue:
- REGULATORY INSIGHT
Compulsory licenses in Germany: a tool for licensing negotiations?
Christof Höhne, Partner at EIP
Preparing for a no-deal Brexit
Nikki Withers speaks to the European Medicines Agency
- MASS SPECTROMETRY
Identification of peptides and proteins in suspected illegal medicinal products using MALDI-TOF-MS
Henrik Lodén, Torgny Rundlöf and Ahmad Amini, Swedish Medical Products Agency
The potential of blockchain in a regulatory environment
Nikki Withers speaks to Bob Celeste, founder of the Centre for Supply Chain Studies
Near-infrared spectroscopy in a bypass system
Christian Huck, Leopold-Franzens University
- SINGLE USE
Partnerships and incorporation: paving the way to a bright future for single-use bioprocessing
Swamini Kulkarni, Allied Market Research
Pharmaceutical packaging: child resistant, easy opening, sustainable
Stephen Wilkins, Chairman, Child Safe Packaging Group
This issue is restricted - login or subscribe free to access
Thank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.
Why subscribe? Join our growing community of thousands of industry professionals and gain access to:
- bi-monthly issues in print and/or digital format
- case studies, whitepapers, webinars and industry-leading content
- breaking news and features
- our extensive online archive of thousands of articles and years of past issues
- ...And it's all free!